Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen

Breast Cancer Research and Treatment

Volumn 27, Issue 3, 1993, Pages 277-281

  Cathcart, Cynthia K ^a   Jones, Stephen E ^a   Pumroy, C Sue ^a   Peters, George N ^a   Knox, Sally M ^a   Cheek, J Harold ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

antiestrogens; breast cancer; depression; tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; DEPRESSION; FEMALE; HUMAN; LYMPHATIC METASTASIS; MIDDLE AGE; TAMOXIFEN;

EID: 0027332652     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF00665698     Document Type: Article

References (8)

1. Tamoxifen in the treatment of breast cancer
2. Symptoms associated with tamoxifen treatment in postmenopausal women
3. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry
4. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers
5. Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy
6. Tamoxifen prophylaxis in breast cancer
7. Prevention of breast cancer with tamoxifen
8. Endocrine treatment of breast cancer in women